Bench­mark re­ports bumper rev­enues

Yorkshire Post - Business - - BUSINESS / NEWS -

Biotech:

Bench­mark Hold­ings, which de­vel­ops vac­cines to keep fish healthy rather than us­ing an­tibi­otics to treat dis­ease, has re­ported sig­nif­i­cant growth in rev­enues and un­der­ly­ing profit ahead of mar­ket ex­pec­ta­tions.

The Sh­effield-based firm re­ported a 7 per cent in­crease in rev­enue to £150m for the year to the end of Septem­ber. EBITDA rose 65 per cent to £16.5m.

The group said mar­ket con­di­tions in its core salmon and shrimp mar­kets re­main favourable and the out­look is pos­i­tive, with strong de­mo­graphic and sus­tain­abil­ity driv­ers.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.